← All organizations
Highest phase reached
Phase 2
First clinical trial
Sep 10, 2024Last known activity
Aug 18, 2025
Timeline
2020s
- Jan 1, 2023
Tisento Therapeutics— Founded
Drugs by trial phase (1 distinct, 2 trials)
Phase 2 (1 own, 0 via acquisition)
Recent trials (2)
- NCT06961344Lead sponsorPhase 2Aug 18, 2025
- NCT06402123Lead sponsorPhase 2Sep 10, 2024
Details
- Founded
- Boston, MA, US Jan 1, 2023
- Last known activity
- Aug 18, 2025